One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1136/annrheumdis-2016-eular.1314
Copy DOI
Export
Save
Share
Cite Journal: Annals of the Rheumatic Diseases |  Publication Date: Jun 1, 2016 |
Affiliation: Amgen (United States), Azienda Ospedaliero-Universitaria Careggi, University of Florence, University Hospital of Bern, Medical University of Graz, University of California, San Francisco, Hôpital Edouard Herriot, Leiden University Medical Center, University of British Columbia, Université Laval
BackgroundOsteoporosis is an important chronic disease, requiring prolonged treatment. Long-term efficacy and safety data are therefore of great importance. Denosumab (DMAb) is used in over 80 countries or administrative districts...
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
